It appears that the total number of CD3−CD19−NKp46+ cells in the spleen is higher in WT than in ST2−/− mice prior to tumor inoculation (Fig. 4A) and decreases after tumor challenge. This evidence concerns the gene IL1RL1 and neoplasm.